Oefner C, D'Arcy A, Hennig M, Winkler F K, Dale G E
Pharma Preclinical Research, F. Hoffmann-La Roche Ltd., Basel, CH-4070, Switzerland.
J Mol Biol. 2000 Feb 18;296(2):341-9. doi: 10.1006/jmbi.1999.3492.
Neutral endopeptidase is a mammalian type II integral membrane zinc-containing endopeptidase, which degrades and inactivates a number of bioactive peptides. The range of substrates cleaved by neutral endopeptidase in vitro includes the enkephalins, substance P, endothelin, bradykinin and atrial natriuretic factor. Due to the physiological importance of neutral endopeptidase in the modulation of nociceptive and pressor responses there is considerable interest in inhibitors of this enzyme as novel analgesics and anti-hypertensive agents. Here we describe the crystal structure of the extracellular domain (residues 52-749) of human NEP complexed with the generic metalloproteinase inhibitor phosphoramidon at 2.1 A resolution. The structure reveals two multiply connected folding domains which embrace a large central cavity containing the active site. The inhibitor is bound to one side of this cavity and its binding mode provides a detailed understanding of the ligand-binding and specificity determinants.
中性内肽酶是一种哺乳动物的II型整合膜含锌内肽酶,它能降解并使多种生物活性肽失活。中性内肽酶在体外切割的底物范围包括脑啡肽、P物质、内皮素、缓激肽和心钠素。由于中性内肽酶在调节伤害性感受和升压反应方面具有生理重要性,因此人们对该酶的抑制剂作为新型镇痛药和抗高血压药物非常感兴趣。在此,我们描述了人NEP细胞外结构域(残基52 - 749)与通用金属蛋白酶抑制剂磷酰胺素复合的晶体结构,分辨率为2.1 Å。该结构揭示了两个多重连接的折叠结构域,它们围绕着一个包含活性位点的大中央腔。抑制剂结合在这个腔的一侧,其结合模式为配体结合和特异性决定因素提供了详细的理解。